1. Home
  2. UTG vs XENE Comparison

UTG vs XENE Comparison

Compare UTG & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTG
  • XENE
  • Stock Information
  • Founded
  • UTG 2003
  • XENE 1996
  • Country
  • UTG United States
  • XENE Canada
  • Employees
  • UTG N/A
  • XENE N/A
  • Industry
  • UTG Investment Managers
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTG Finance
  • XENE Health Care
  • Exchange
  • UTG Nasdaq
  • XENE Nasdaq
  • Market Cap
  • UTG 3.3B
  • XENE 2.9B
  • IPO Year
  • UTG N/A
  • XENE 2014
  • Fundamental
  • Price
  • UTG $38.58
  • XENE $40.89
  • Analyst Decision
  • UTG
  • XENE Strong Buy
  • Analyst Count
  • UTG 0
  • XENE 10
  • Target Price
  • UTG N/A
  • XENE $53.00
  • AVG Volume (30 Days)
  • UTG 317.8K
  • XENE 820.4K
  • Earning Date
  • UTG 01-01-0001
  • XENE 11-11-2025
  • Dividend Yield
  • UTG 7.28%
  • XENE N/A
  • EPS Growth
  • UTG N/A
  • XENE N/A
  • EPS
  • UTG 9.86
  • XENE N/A
  • Revenue
  • UTG $96,107,593.00
  • XENE $7,500,000.00
  • Revenue This Year
  • UTG N/A
  • XENE N/A
  • Revenue Next Year
  • UTG N/A
  • XENE $207.88
  • P/E Ratio
  • UTG $3.20
  • XENE N/A
  • Revenue Growth
  • UTG 8.35
  • XENE N/A
  • 52 Week Low
  • UTG $25.26
  • XENE $26.74
  • 52 Week High
  • UTG $35.29
  • XENE $46.00
  • Technical
  • Relative Strength Index (RSI)
  • UTG 44.29
  • XENE 53.97
  • Support Level
  • UTG $37.06
  • XENE $41.09
  • Resistance Level
  • UTG $41.94
  • XENE $44.23
  • Average True Range (ATR)
  • UTG 0.81
  • XENE 1.50
  • MACD
  • UTG -0.40
  • XENE -0.03
  • Stochastic Oscillator
  • UTG 31.22
  • XENE 41.46

About UTG Reaves Utility Income Fund of Beneficial Interest

Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: